YAP1 and colorectal carcinoma: In line with this, Lee and colleagues extracted a YAP1 gene activation signature from CRC cell microarray data and documented that the activated YAP1 signature was associated with poor prognosis across four stages I to III CRC cohorts, including the two cohorts analysed in the Yuen study [20].